curating and sharing structures and spectra for the

31
1 Curating and Sharing Structures and Spectra for the Environmental Community Emma Schymanski Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg. Email: [email protected] Antony J. Williams (NCCT, US EPA, Research Triangle Park, NC, USA) Image © www.seanoakley.com/ The views expressed in this presentation are those of the authors and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency.

Upload: others

Post on 12-Dec-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

1

Curating and Sharing Structures and Spectra for the

Environmental Community

Emma SchymanskiLuxembourg Centre for Systems Biomedicine (LCSB) University of Luxembourg

Email emmaschymanskiunilu

Antony J Williams (NCCT US EPA Research Triangle Park NC USA)

Image copy wwwseanoakleycom

The views expressed in this presentation are those of the authors and do not necessarily reflect the views or policies of the US Environmental Protection Agency

2

The Goal

Aligizakis et al in prep

o To identify as many substances in environmental samples with high resolution mass spectrometry as possible

NORMAN Digital Sample Freezing Platform- Retrospective screening across Europe

3

The Goal

o To identify as many substances in environmental samples with high resolution mass spectrometry as possible

o To do this we needbull Mass Spectra in reference libraries bull Metadata

(and fancy computational methods hellip but thatrsquos another storyhellip)

4

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

5

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

6

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

7

MetFrag23 Non-target Identification

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

Status 2010 =gt 2016

5 ppm0001 Da

mz [M-H]-

2139637ChemSpider

orPubChemplusmn 5 ppm

23

RT 454 min355 InChIRTs

ReferencesExternal RefsData SourcesRSC CountPubMed Count

Suspect Lists

MSMS1340054 3396891500001 772712139607 632466

Elements CNS

S OO

OH

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

2

The Goal

Aligizakis et al in prep

o To identify as many substances in environmental samples with high resolution mass spectrometry as possible

NORMAN Digital Sample Freezing Platform- Retrospective screening across Europe

3

The Goal

o To identify as many substances in environmental samples with high resolution mass spectrometry as possible

o To do this we needbull Mass Spectra in reference libraries bull Metadata

(and fancy computational methods hellip but thatrsquos another storyhellip)

4

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

5

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

6

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

7

MetFrag23 Non-target Identification

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

Status 2010 =gt 2016

5 ppm0001 Da

mz [M-H]-

2139637ChemSpider

orPubChemplusmn 5 ppm

23

RT 454 min355 InChIRTs

ReferencesExternal RefsData SourcesRSC CountPubMed Count

Suspect Lists

MSMS1340054 3396891500001 772712139607 632466

Elements CNS

S OO

OH

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

3

The Goal

o To identify as many substances in environmental samples with high resolution mass spectrometry as possible

o To do this we needbull Mass Spectra in reference libraries bull Metadata

(and fancy computational methods hellip but thatrsquos another storyhellip)

4

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

5

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

6

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

7

MetFrag23 Non-target Identification

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

Status 2010 =gt 2016

5 ppm0001 Da

mz [M-H]-

2139637ChemSpider

orPubChemplusmn 5 ppm

23

RT 454 min355 InChIRTs

ReferencesExternal RefsData SourcesRSC CountPubMed Count

Suspect Lists

MSMS1340054 3396891500001 772712139607 632466

Elements CNS

S OO

OH

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

4

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

5

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

6

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

7

MetFrag23 Non-target Identification

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

Status 2010 =gt 2016

5 ppm0001 Da

mz [M-H]-

2139637ChemSpider

orPubChemplusmn 5 ppm

23

RT 454 min355 InChIRTs

ReferencesExternal RefsData SourcesRSC CountPubMed Count

Suspect Lists

MSMS1340054 3396891500001 772712139607 632466

Elements CNS

S OO

OH

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

5

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

6

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

7

MetFrag23 Non-target Identification

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

Status 2010 =gt 2016

5 ppm0001 Da

mz [M-H]-

2139637ChemSpider

orPubChemplusmn 5 ppm

23

RT 454 min355 InChIRTs

ReferencesExternal RefsData SourcesRSC CountPubMed Count

Suspect Lists

MSMS1340054 3396891500001 772712139607 632466

Elements CNS

S OO

OH

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

6

The Power of the Metadata (Top 1 ranks)

Schymanski et al 2017 J Cheminf DOI 101186s13321-017-0207-1 wwwcasmi-contestorg

7

MetFrag23 Non-target Identification

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

Status 2010 =gt 2016

5 ppm0001 Da

mz [M-H]-

2139637ChemSpider

orPubChemplusmn 5 ppm

23

RT 454 min355 InChIRTs

ReferencesExternal RefsData SourcesRSC CountPubMed Count

Suspect Lists

MSMS1340054 3396891500001 772712139607 632466

Elements CNS

S OO

OH

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

7

MetFrag23 Non-target Identification

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

Status 2010 =gt 2016

5 ppm0001 Da

mz [M-H]-

2139637ChemSpider

orPubChemplusmn 5 ppm

23

RT 454 min355 InChIRTs

ReferencesExternal RefsData SourcesRSC CountPubMed Count

Suspect Lists

MSMS1340054 3396891500001 772712139607 632466

Elements CNS

S OO

OH

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

8

Non-target Identification and Metadata

Example from Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

o Helps prioritize interesting candidates rapidly hellipo hellipassuming candidates are in databases hellip o httpsmsbiipb-halledeMetFragBeta

Ruttkies Schymanski Wolf Hollender Neumann (2016) J Cheminf 2016 DOI 101186s13321-016-0115-9

One candidate stands out already

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

9

Suspect Screening Allows Efficient Data Exploration

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

10

NORMAN Suspect Exchange amp SusDato httpwwwnorman-networkcomq=node236

Schymanski Aalizadeh et al in prep

ReferencesFull Lists InChIKeys

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

11

o Now 23 lists available online hellip from small to large

Specialised Lists through to Market Lists

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

12

hellipbut not all are what they seemhellip

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

13

Example Eawag Surfactant List

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

14

Eawag Surfactant List (after many late nightshellip)

Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

httpscomptoxepagovdashboardchemical_listseawagsurf

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

15

Eawag Surfactant List in CompTox Dashboard

Schymanski Grulke Williams et al in prep amp Williams et al 2017 J Cheminformatics 961 DOI 101186s13321-017-0247-6

httpscomptoxepagovdashboardchemical_listseawagsurf

CDK Depict

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

16

Cross-Linking with Lists in CompTox Dashboard

See next slide hellip

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

17

Supporting Evidence for Homologues

Stravs et al (2013) J Mass Spectrom 48(1)89-99 DOI 101002jms3131

OHSO

O

CH3

O

OHm n

SPA-9C

m+n=6

Formulas httpsourceforgenetprojectsgenformMeringer et al 2011 MATCH 65 259-290Data Schymanski et al 2014 ESampT 48 1811-1818 DOI 101021es4044374

Chromatography and MSMS Annotation

Literature LIT0003435Sample ETS00002Standard ETS00016171920

httpsgithubcomMassBankRMassBank

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

18

Using Generic Structures for ScreeningLinking

o httpsgithubcomschymaneRChemMass

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

19

Toolkit compatibility will be vital for us hellip

o httpsgithubcomcdkdepictissues7

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

20

hellip to enable world-wide exchange of suspects

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

NORMAN Suspect List Exchange httpwwwnorman-networkcomq=node236

Tentatively Identified Spectra httpgoogl0t7jGp

Hits in GNPS MassIVE datasetsTPs in skin httpgooglNmO4txSurfactants httpgoogl7sY9Pf

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

21

Acknowledgements

emmaschymanskiuniluFurther Informationwwwmassbankeu

httpwwwnorman-networkcomq=node236httpsgithubcomMassBankRMassBank

httpscomptoxepagovdashboardhttpswwwenunilulcsb

eu

23

EU Grant 603437

Stellan FischerKEMI

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

22

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

23

2015 European Non-target Screening Trial

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

CroatianWater

RWS

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

24

Homologous Series Detection

M Loos amp H Singer 2017 J Cheminf DOI 101186s13321-017-0197-z amp Schymanski et al 2014 ESampT DOI 101021es4044374

httpwwwenvihomologeawagch

Search for discrete mass differences S OO

OH

CH3CH3

m

n

C9H19

OO

S

O

O

OHm

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

25

Surfactant Screening From Literature

Schymanski et al (2014) ESampT 48 1811-1818 DOI 101021es4044374

Literature sourceso Formulas masses (ions) retention times and intensitieso Spectra of selected compounds (different instruments)

Gonzalez et al Rapid Comm Mass Spec 2008 22 1445-54

Lara-Martin et al EST 2010 44 1670-1676

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

26

2015 European Non-target Screening Trial

Schymanski et al 2014 ESampT DOI 101021es5002105 amp Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

Peak picking

Non-target HR-MS(MS) Acquisition

TargetScreening

SuspectScreening

Non-targetScreening

StartLevel 1 Confirmed Structure

by reference standard

Level 2 Probable Structureby librarydiagnostic evidence

StartLevel 3 Tentative Candidate(s)

suspect substructure class

Level 4 Unequivocal Molecular Formulainsufficient structural evidence

StartLevel 5 Mass of Interest

multiple detection trends hellip

ldquodowngradingrdquo with contradictory evidence

Increasing identificationconfidence

Target list Suspect list

Peak picking or XICs

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

27

Reported Identification Depended on Source List

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

TerbutylazineDetects 12 Refs 220

SebutylazineDetects 3 Refs 51

PropazineDetects 3 Refs 201C 9

H 16C

lN5

mz

229

109

4 Da

N

NN

Cl

NH

CH3

NH CH3

CH3

CH3

(no related compound at

this mass)N

NN

Cl

NH CH3NH

CH3

CH3N

NN

Cl

NH CH3NH

CH3

CH3

CH3

SimazineDetects 4 Refs 518

Terbutylazine-desethylDetects 9 Refs 92

Sebutylazine-desethylDetects 1 Refs 14

C 7H 1

2ClN

5

mz

201

078

1 Da

N

NN

Cl

NH2NH

CH3

CH3

CH3

N

NN

Cl

NH2NH

CH3

CH3 N

NN

Cl

NHNH CH3CH3

(no related compound at

this mass)

Terbutylazine-desethyl-2-hydroxy

Detects 2 Refs 57

Sebutylazine-desethyl-2-hydroxy

Detects 0 Refs 3

Simazine-2-hydroxy

Detects 2 Refs 66

C 7H 1

3N5O

mz

183

112

0 Da

N

NN

NH2NH

OH

CH3

CH3

CH3

N

NN

OH

NH2NH

CH3

CH3N

NN

OH

NHNH CH3CH3

(no related compound at

this mass)

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

28

Enter NORMAN Suspect Exchange

Schymanski et al 2015 ABC DOI 101007s00216-015-8681-7

o hellippart of the NORMAN Databases Collection

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

29

Eawag Surfactant List in CompTox Dashboard

CDK Depict

httpswwwslidesharenetAntonyWilliamsmarkush-enumeration-to-manage-mesh-and-manipulate-substances-of-unknown-or-variable-composition

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

30

Curation never stops hellip

(many) more registrationshellip

Cleaning up lists to remove errorsUndefined mixtures (UVCBs)

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening

31

Target Suspect and Non-Target Screening

KNOWNS SUSPECTS No Prior Knowledge

HPLC separation and HR-MSMS

TARGET ANALYSIS

SUSPECT SCREENING

NON-TARGETSCREENING

Targets found Suspects found Masses of interest

(Molecular formula)

DATABASE SEARCH

STRUCTUREGENERATION

Confirmation and quantification of compounds present

Candidate selection (retention time MSMS calculated properties)

Sampling extraction (SPE) HPLC separation HR-MSMS

Time Effort amp Number of Compoundshellip

SUSPECTS

SPECTRUM SEARCH

Spectral match

  • Slide Number 1
  • The Goal
  • The Goal
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • MetFrag23 Non-target Identification
  • Non-target Identification and Metadata
  • Suspect Screening Allows Efficient Data Exploration
  • NORMAN Suspect Exchange amp SusDat
  • Specialised Lists through to Market Lists
  • hellipbut not all are what they seemhellip
  • Example Eawag Surfactant List
  • Eawag Surfactant List (after many late nightshellip)
  • Eawag Surfactant List in CompTox Dashboard
  • Cross-Linking with Lists in CompTox Dashboard
  • Supporting Evidence for Homologues
  • Using Generic Structures for ScreeningLinking
  • Toolkit compatibility will be vital for us hellip
  • hellip to enable world-wide exchange of suspects
  • Acknowledgements
  • Slide Number 22
  • 2015 European Non-target Screening Trial
  • Homologous Series Detection
  • Surfactant Screening From Literature
  • 2015 European Non-target Screening Trial
  • Reported Identification Depended on Source List
  • Enter NORMAN Suspect Exchange
  • Eawag Surfactant List in CompTox Dashboard
  • Curation never stops hellip
  • Target Suspect and Non-Target Screening